ATE514793T1 - Zusammensetzungen und verfahren für il13- biomarker - Google Patents
Zusammensetzungen und verfahren für il13- biomarkerInfo
- Publication number
- ATE514793T1 ATE514793T1 AT06815683T AT06815683T ATE514793T1 AT E514793 T1 ATE514793 T1 AT E514793T1 AT 06815683 T AT06815683 T AT 06815683T AT 06815683 T AT06815683 T AT 06815683T AT E514793 T1 ATE514793 T1 AT E514793T1
- Authority
- AT
- Austria
- Prior art keywords
- compositions
- methods
- biomarkers
- measuring
- determining biomarkers
- Prior art date
Links
- 102000003816 Interleukin-13 Human genes 0.000 title abstract 2
- 108090000176 Interleukin-13 Proteins 0.000 title abstract 2
- 239000000090 biomarker Substances 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/52—Assays involving cytokines
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/12—Pulmonary diseases
- G01N2800/122—Chronic or obstructive airway disorders, e.g. asthma COPD
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Analytical Chemistry (AREA)
- Genetics & Genomics (AREA)
- Pathology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Biophysics (AREA)
- General Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US72229605P | 2005-09-30 | 2005-09-30 | |
| PCT/US2006/037856 WO2007041219A2 (en) | 2005-09-30 | 2006-09-29 | Compositions and methods for il13 biomarkers |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE514793T1 true ATE514793T1 (de) | 2011-07-15 |
Family
ID=37906704
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT06815683T ATE514793T1 (de) | 2005-09-30 | 2006-09-29 | Zusammensetzungen und verfahren für il13- biomarker |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US7875427B2 (de) |
| EP (1) | EP1943359B1 (de) |
| AT (1) | ATE514793T1 (de) |
| WO (1) | WO2007041219A2 (de) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MY144906A (en) | 2005-10-21 | 2011-11-30 | Novartis Ag | Human antibodies against il13 and therapeutic uses |
| CN104812913B (zh) | 2012-11-07 | 2019-03-15 | 私募蛋白质体公司 | 慢性阻塞性肺疾病(copd)生物标记及其用途 |
| BR112016008694A2 (pt) * | 2013-10-23 | 2017-10-03 | Genentech Inc | Métodos de previsão da reação de pacientes com asma, de previsão da capacidade de reação de pacientes com asma, de identificação de pacientes com asma, de tratamento de pacientes portadores de asma e de tratamento de asma, uso de um kit e kit |
| EA037960B1 (ru) | 2016-04-27 | 2021-06-15 | Эббви Инк. | Способ лечения эозинофильного эзофагита с применением антитела против il-13 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6194163B1 (en) * | 1995-07-21 | 2001-02-27 | The Provost, Fellows And Scholars Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth Near Dublin | Method for the quantitative measurement of human acute phase serum amyloid A protein; recombinant protein; specific antibody |
| US5853697A (en) * | 1995-10-25 | 1998-12-29 | The United States Of America, As Represented By The Department Of Health & Human Services | Methods of treating established colitis using antibodies against IL-12 |
| JP4155561B2 (ja) | 2000-12-26 | 2008-09-24 | 国立大学法人佐賀大学 | アレルギー性疾患検査方法 |
| JP2004121218A (ja) | 2002-08-06 | 2004-04-22 | Jenokkusu Soyaku Kenkyusho:Kk | 気管支喘息または慢性閉塞性肺疾患の検査方法 |
| MXPA05007466A (es) * | 2003-01-09 | 2006-03-08 | Arizeke Pharmaceuticals Inc | Metodos para el tratamiento de enfermedades pulmonares. |
| WO2006124451A2 (en) | 2005-05-11 | 2006-11-23 | Centocor, Inc. | Anti-il-13 antibodies, compositions, methods and uses |
-
2006
- 2006-09-29 EP EP06815683A patent/EP1943359B1/de not_active Not-in-force
- 2006-09-29 WO PCT/US2006/037856 patent/WO2007041219A2/en not_active Ceased
- 2006-09-29 AT AT06815683T patent/ATE514793T1/de not_active IP Right Cessation
- 2006-09-29 US US11/536,704 patent/US7875427B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| WO2007041219A3 (en) | 2007-10-04 |
| US20070077585A1 (en) | 2007-04-05 |
| WO2007041219A2 (en) | 2007-04-12 |
| US7875427B2 (en) | 2011-01-25 |
| HK1123073A1 (en) | 2009-06-05 |
| EP1943359B1 (de) | 2011-06-29 |
| EP1943359A4 (de) | 2009-10-14 |
| EP1943359A2 (de) | 2008-07-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1869462A4 (de) | Biomarker für ovarialkrebs und endometriumkrebs: hepcidin | |
| DE602006001278D1 (de) | Messinstrument für Oberflächenprofile | |
| ATE424904T1 (de) | Bausatz für komplexe konstruktionen | |
| DE602006015521D1 (de) | Messstreifen und verfahren für lateralfluss-testvorrichtungen | |
| DE602006003488D1 (de) | Einführeinrichtung für ein Instrument | |
| EP1901654A4 (de) | Messinstrument für perkutane operationen | |
| DE602006017421D1 (de) | Screening-verfahren für kokumi-vermittelnde agentien | |
| DE602005009994D1 (de) | Kalibration für Mixed Reality | |
| EP1838732A4 (de) | Biomarker für melanome | |
| ATE449193T1 (de) | Verfahren zur bestimmung der kopienummer | |
| DE602006009202D1 (de) | Formmessgerät | |
| AR059096A1 (es) | Anticuerpos anti- efrina -b2 y metodos que usan estos | |
| DE602005005924D1 (de) | Einheitliches Datenformat für Messgeräte | |
| DE602005016800D1 (de) | Hif-prolylhydroxylase-aktivitätstest | |
| DE602004000991D1 (de) | Gleitstruktur für Klavierinstrument | |
| EP2300624A4 (de) | Biomarker für schmerzhafte bandscheiben und verwendungsverfahren dafür | |
| DE602006005208D1 (de) | Tonerzusammensetzung und Verfahren | |
| DE602005003146D1 (de) | Polymer- Zusamensetzungen für verbesserte Materialien | |
| DE602006015887D1 (de) | Wiederaufnamesystem für Luftschiffe | |
| ATE514793T1 (de) | Zusammensetzungen und verfahren für il13- biomarker | |
| DE602006009513D1 (de) | Verwendung von phenylsemicarbazonen für die saatgutbeizung | |
| DE602006015735D1 (de) | Bodenbeschichtungszusammensetzung und Verwendung eines Zusatzes für Bodenbeschichtungszusammensetzung | |
| DE602005003637D1 (de) | Dichtung für Dämpfer | |
| DE502005010620D1 (de) | Obergurtquerschnitt für Kranteleskopteile | |
| EP2403843A4 (de) | Chemilumineszente zusammensetzungen, verfahren, tests und kits für oxidative enzyme |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |